Ginsenoside Re Description

Ginsenoside Re is a triterpene saponin originally begin in breed of Panax that exhibits antioxidative, anti-ulcerative, anti-inflammatory, neuroprotective, anxiolytic, antidepressant, anti-diabetic, anti-allergic, cardioprotective, and immunostimulatory activities. Ginsenoside Re inhibits accumulation of belly mucosal lesions in vivo by accretion mucosal secretion, abbreviating neutrophil infiltration, and suppressing myeloperoxidase and xanthine oxidase activity. In beastly models of immunization, ginsenoside Re acts as an adjuvant, accretion the CD4+:CD8+ corpuscle ratio, accretion antibiotic titers, and accretion levels of IL-4, IL-10, IL-12, and IFN-γ.

Ginsenoside Re improves affection rate, perfusion pressure, claret flow, and cardiac achievement in beastly models of myocardial ischemia/reperfusion. Additionally, ginsenoside Re inhibits histamine absolution in mast beef and decreases LPS-stimulated assembly of COX-2 and iNOS in microglia. In adipocytes, this admixture activates PPARγ signaling, induces adipogenesis, and increases glucose uptake. In vivo, ginsenoside Re inhibits stress-induced anxiety, depression, and cerebral deficits.